Pregnancy in women with mitochondrial disease-A literature review and suggested guidance for preconception and pregnancy care.
Lisa Hui, Pema Hayman, Ali Buckland, Michael C Fahey, David A Mackey, Andrew J Mallett, Daniel R Schweitzer, Clare P Stuart, Wai Yan Yau, John Christodoulou
Author Information
Lisa Hui: Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, Victoria, Australia. ORCID
Pema Hayman: College of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia. ORCID
Ali Buckland: Department of Neurology, Perron Institute for Neurological and Translational Science, Perth, Western Australia, Australia.
Michael C Fahey: Department of Paediatrics, Monash University, Melbourne, Victoria, Australia. ORCID
David A Mackey: Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia. ORCID
Andrew J Mallett: College of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia. ORCID
Daniel R Schweitzer: Department of Neurology, Mater Hospital, Brisbane, Queensland, Australia.
Clare P Stuart: Mito Foundation, Sydney, New South Wales, Australia. ORCID
Wai Yan Yau: Department of Neurology, Perron Institute for Neurological and Translational Science, Perth, Western Australia, Australia. ORCID
John Christodoulou: Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia. ORCID
Mitochondrial donation to reduce the risk of primary mitochondrial disease transmission from mother to child is now permitted under Australian law as part of a clinical trial. The energy demands of pregnancy have the potential to worsen mitochondrial disease symptoms and severity in affected women. We conducted a systematic literature review on mitochondrial disease in pregnancy; five cohort studies and 19 case reports were included. For many women with mitochondrial disease, pregnancy does not have a negative effect on health status. However, serious adverse outcomes may occur. We provide suggested guidelines for preconception counselling and antenatal care.
Sue CM, Balasubramaniam S, Bratkovic D et al. Patient care standards for primary mitochondrial disease in Australia: An Australian adaptation of the mitochondrial medicine society recommendations. Intern Med J 2022; 52(1): 110–120.
Mito Foundation. Understanding mito. Accessed December 20, 2023. https://www.mito.org.au/about‐mito/mitochondrial‐disease/.
Gorman GS, Schaefer AM, Ng Y et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015; 77(5): 753–759.
Mitochondrial Donation Law Reform (Maeve's Law) Bill. 2021.
Mitochondrial donation. Updated 02/02/2021. Accessed 11 February 2024. https://www.newcastle‐hospitals.nhs.uk/services/fertility‐treatment/mitochondrial‐donation/
Monash University Discovery Institute News and Events. Monash University Heads $15M Mitochondrial Donation Clinical Trial. Accessed 11 February 2024. https://www.monash.edu/discovery‐institute/news‐and‐events/news/2023‐articles/monash‐university‐heads‐$15m‐mitochondrial‐donation‐clinical‐trial.
Finsterer J. Obstetric involvement in mitochondrial disorders: A review. Medicine 2023; 102(11): e33336.
Turnbull H, Say R, Smith M et al. Newcastle mitochondrial disease guidelines. Pregnancy in Mitochondrial Disease. 2011. https://www.newcastle‐mitochondria.com/wp‐content/uploads/2016/03/Pregnancy‐Guidelines.pdf.
Karaa A, Elsharkawi I, Clapp MA, Balcells C. Effects of mitochondrial disease/dysfunction on pregnancy: A retrospective study. Mitochondrion 2019; 46: 214–220.
Kuleva M, Ben Miled S, Steffann J et al. Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations: A retrospective cohort study in a single tertiary centre. BJOG 2019; 126(11): 1372–1379.
Feeney CL, Lim AZ, Fagan E et al. A case‐comparison study of pregnant women with mitochondrial disease – what to expect? BJOG 2019; 126(11): 1380–1389.
Friedman LS, Paulsen EK, Schadt KA et al. Pregnancy with Friedreich ataxia: A retrospective review of medical risks and psychosocial implications. Am J Obstet Gynecol 2010; 203(3): 224.e1–224.e5. https://doi.org/10.1016/j.ajog.2010.03.046.
de Laat P, Fleuren LHJ, Bekker MN et al. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. Mitochondrion 2015; 25: 98–103.
Bell JD, Higgie K, Joshi M et al. Anesthetic Management of Mitochondrial Encephalopathy with Lactic Acidosis and Stroke‐like Episodes (MELAS syndrome) in a high‐risk pregnancy: A case report. A & A Case Reports 2017; 9(2): 38–41. https://doi.org/10.1213/XAA.0000000000000520.
Sanchez MV, Romero R. Acute pulmonary edema secondary to pregnancy in a patient with the mitochondrial disease MELAS. Rev Esp Cardiol 2010; 63(5): 615–617.
Annaiah TK, Kodakkattil S, Sriemevan A. Pregnancy with mitochondrial encephalopathy lactic acidosis and stroke‐like episodes (MELAS syndrome) leading to confusion in the diagnosis of pulmonary embolism. J Obstet Gynaecol 2007; 27(6): 618–619.
Shi H, Waldman G, Tobochnik S et al. Clinical reasoning: Refractory status epilepticus in a primigravida. Neurology 2019; 92(20): 968–972.
Yuan N, El‐Sayed YY, Ruoss SJ et al. Successful pregnancy and cesarean delivery via noninvasive ventilation in mitochondrial myopathy. J Perinatol 2009; 29(2): 166–167.
Diaz‐Lobato S, Gomez Mendieta MA, Moreno Garcia MS et al. Two full‐term pregnancies in a patient with mitochondrial myopathy and chronic ventilatory insufficiency. Respiration 2005; 72(6): 654–656.
Yamamoto H, Tachibana D, Tajima G et al. Successful management of pregnancy with very‐long‐chain acyl‐coenzyme a dehydrogenase deficiency. J Obstet Gynaecol Res 2015; 41(7): 1126–1128.
Pappalardo P, Benoist J‐F, Bax BE et al. Pregnancy in MNGIE: A clinical and metabolic honeymoon. Ann Clin Transl Neurol 2020; 7(12): 2484–2488.
Faris AS, Tawfic QA, Jeyaraj L. Obstetric anesthesia considerations in Kearns‐Sayre syndrome: A case report. Korean J Anesthesiol 2014; 67(4): 283–286.
Hosono T, Suzuki M, Chiba Y. Contraindication of magnesium sulfate in a pregnancy complicated with late‐onset diabetes mellitus and sensory deafness due to mitochondrial myopathy. J Matern Fetal Med 2001; 10(5): 355–356. https://doi.org/10.1080/714052760.
Trakadis Y, Kadlubowska D, Barnes R et al. Pregnancy of a patient with multiple acyl‐CoA dehydrogenation deficiency (MADD). Mol Genet Metab 2012; 106(4): 491–494.
Williams SF, Alvarez JR, Pedro HF, Apuzzio JJ. Glutaric aciduria type II and narcolepsy in pregnancy. Obstet Gynecol 2008; 111(2 Pt 2): 522–524.
National Health and Medical Research Council. Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and Research. Canberra: National Health and Medical Research Council, 2017; Accessed on 15 Dec 2023 at www.nhmrc.gov.au/guidelines‐publications/e79.
Heindryckx B, Neupane J, Vandewoestyne M et al. Mutation‐free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke‐like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis. Mitochondrion 2014; 18: 12–17.
Maurtua M, Torres A, Ibarra V et al. Anesthetic management of an obstetric patient with MELAS syndrome: Case report and literature review. Int J Obstet Anesth 2008; 17(4): 370–373.
Moriarty KT, McFarland R, Whittaker R et al. Pre‐eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A>G melas mutation. J Obstet Gynaecol 2008; 28(3): 349.
Chou Y‐J, Ou C‐Y, Hsu T‐Y et al. Prenatal diagnosis of a fetus harboring an intermediate load of the A3243G mtDNA mutation in a maternal carrier diagnosed with MELAS syndrome. Prenat Diagn 2004; 24(5): 367–370.
Armstrong BA, Howat PW. Pregnancy in a woman with Friedreich's ataxia complicated by pulmonary embolism. Aust N Z J Obstet Gynaecol 2002; 42(1): 88–90.
Dessole S, Capobianco G, Ambrosini G, Battista NG. Postpartum hemorrhage and emergency hysterectomy in a patient with mitochondrial myopathy: A case report. Arch Gynecol Obstet 2003; 267(4): 247–249.
Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Best Practice Statement. Pre‐pregnancy Counselling. Accessed on 26 Feb 2024. https://ranzcog.edu.au/wp‐content/uploads/2022/05/Pre‐pregnancy‐Counselling.pdf.
Bromley R, Adab N, Bluett‐Duncan M et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2023; 8(8): CD010224 doi: 10.1002/14651858.CD010224.pub3.
Lowe SA, Bowyer L, Lust K et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol 2015; 55(5): e1–e29. https://doi.org/10.1111/ajo.12399.
Rudland VL, Price SAL, Hughes R et al. ADIPS 2020 guideline for pre‐existing diabetes and pregnancy. Aust N Z J Obstet Gynaecol 2020; 60(6): E18–E52. https://doi.org/10.1111/ajo.13265.
Tomson T, Battino D, Bromley R et al. Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord 2019; 21(6): 497–517. https://doi.org/10.1684/epd.2019.1105.
Lowe SA, Bowyer L, Beech A et al. Guideline for the management of nausea and vomiting in pregnancy and hyperemesis gravidarum. Society for Obstetric Medicine of Australia and New Zealand. 2019. https://www.somanz.org/content/uploads/2020/07/NVP‐GUIDELINE‐1.2.20‐1.pdf.
Tran HA, Gibbs H, Merriman E et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust 2019; 210: 227–235. https://doi.org/10.5694/mja2.50004.
Lowe SA, Barrett HL, Cutts BA et al. Update on pulmonary embolism in pregnancy and post‐partum: The Society of Obstetric Medicine of Australia and New Zealand Position Statement on Pulmonary Embolism in Pregnancy and Post‐partum. Aust N Z J Obstet Gynaecol 2021; 61(6): 830–836. https://doi.org/10.1111/ajo.13418.
Intrapartum care for women with existing medical conditions or obstetric complications and their babies. 2019 Updated 25 April 2019.